Counterfeit tirzepatide is a real and documented problem. The tells are price far below the market floor, no prescription requirement, 'research use only' labeling, overseas shipping, payment by cryptocurrency or bank transfer, and a product that arrives without pharmacy labeling.
On this page
Price is the first signal
The legitimate compounded floor sits around $99 per month. Active pharmaceutical ingredient, sterile compounding, testing, cold-chain shipping and a prescriber's time have real costs. A $40 vial is not a bargain — it is a different product with unknown contents.
'Research use only' is a legal tell, not a formality
Products labeled for research use are not manufactured to pharmaceutical standards and are not legal to sell for human use. Sellers use the phrase specifically to shift liability to you. There is no legitimate reason for a person to inject a research-grade peptide.
What can go wrong
Documented problems with grey-market GLP-1 products include incorrect dosing concentration, non-sterile preparation, salt forms that are not the approved active ingredient, and dosing errors leading to hospitalisation. Poison-control centers reported sharp increases in GLP-1 exposure calls through 2024–2025, largely driven by dosing confusion and unregulated product.
If you think you received a counterfeit
Stop using it. Photograph everything including packaging and labeling. Contact your clinician. Report to FDA MedWatch and to your state board of pharmacy. If you paid by card, dispute the charge.
Common questions
Does insurance cover tirzepatide?
It depends on your plan and your diagnosis. Many commercial plans exclude weight-management drugs entirely. Zepbound carries a specific FDA indication for moderate-to-severe obstructive sleep apnea with obesity, and plans that exclude weight loss often cover a diagnosed sleep disorder. With type 2 diabetes, Mounjaro is on-label.
What are the most common tirzepatide side effects?
Nausea (roughly 24–33%), diarrhea (19–23%), constipation (16–17%) and vomiting (8–12%). They cluster in the days after each dose increase and usually settle within one to two weeks at each new dose. Constipation is the one that most often persists.
Do I need a prescription for tirzepatide?
Yes, always — for brand and compounded alike. Any seller shipping tirzepatide without a prescription from a licensed prescriber is operating illegally, and the product should not be considered pharmaceutical grade.
Can I switch from semaglutide to tirzepatide without starting over?
You restart at 2.5 mg tirzepatide regardless of your semaglutide dose, because there is no equivalence between the molecules. Most switchers find re-titration far easier than a first start — roughly 13% report GI symptoms — because GLP-1 receptor adaptation carries over. Take the first tirzepatide dose about seven days after your last semaglutide injection.
People also ask about counterfeit tirzepatide
What is counterfeit tirzepatide?
Counterfeit tirzepatide is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.
Does counterfeit tirzepatide apply to compounded tirzepatide as well as Zepbound?
The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.
How much does counterfeit tirzepatide cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is counterfeit tirzepatide FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.